|
Hello
I would be Christine MH-UK, but I am having trouble logging in today.
Hi Geraldine. I just wanted to add that what makes the situation really appalling is that people with certain types of private health insurance can get it, although not others (AXA PPP is not paying, for example, just to give them some bad publicity) and not many patients on the NHS. I was able to get it by paying for it out of pocket, so it's a good thing I'm not fat, but it took my oncologist four months to negotiate around to find a supplier I could afford. BUPA, which providing herceptin to patients with BUPA insurance, wanted £60,000 for a year, but Healthcare at Home was a more reasonable £26,000. Oh well, you can't take it with you and it's less than a Landrover Discovery.
There has been some real movement on getting herceptin generally available on the national health service, which provides health care for most people. In early June of the big cancer charities made public that the NHS's approval of cancer drugs was so slow that herceptin wouldn't be available until February 2008, so of course there was a big uproar and lots of political activism.
A big thank you to everyone who signed the Women Fighting for Herceptin petition. The government has now agreed to speed things up so that herceptin should be available soon after the European Union extends its licence to cover early breast cancer in mid-2006. It has also committed to giving life-saving drugs, such as cancer drugs, priority in considering them for licencing. It does get to me that many high-risk patients aren't getting herceptin.
I'm glad to hear that you are getting it, Geraldine. I hear that there are still some authorities that restrict herceptin use even in women with secondaries by not testing for the trait. Just last week the government announced that all local authorities will have to test newly diagnosed women for her2 status, so with any luck that practice will end.
|